Espersen, Caroline http://orcid.org/0000-0003-2879-8862
Skaarup, Kristoffer Grundtvig
Lassen, Mats Christian Højbjerg
Johansen, Niklas Dyrby
Hauser, Raphael
Olsen, Flemming Javier
Jensen, Gorm Boje
Schnohr, Peter
Møgelvang, Rasmus
Biering-Sørensen, Tor
Funding for this research was provided by:
Gentofte Hospital
Hjerteforeningen
Region Hovedstaden
Royal Library, Copenhagen University Library
Article History
Received: 6 September 2023
Accepted: 23 October 2023
First Online: 15 November 2023
Declarations
:
: TBS reports: Chief investigator of the Boston Scientific financed “DANLOGIC-HF” trial; Chief investigator of the Sanofi Pasteur financed “NUDGE-FLU” trial; Chief investigator of the Sanofi Pasteur financed “DANFLU-1″ trial; Chief investigator of the Sanofi Pasteur financed “DANFLU-2″ trial; Steering Committee member of Boston Scientific sponsored “LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System” trial; Steering Committee member of the Amgen sponsored GALACTIC-HF trial; Steering Committee member of the Boehringer Ingelheim financed EASi-KIDNEY trial; Advisory Board: Sanofi Pasteur, Amgen, CSL Seqirus and GSK; Speaker Honorarium: Bayer, Novartis, Sanofi Pasteur, GE healthcare and GSK; Research grants: Boston Scientific, GE Healthcare, AstraZeneca, Novo Nordisk and Sanofi Pasteur; Consultant appointments: Novo Nordisk, IQVIA and Parexel. KGS reports: Advisory Board: Sanofi Pasteur. All other authors report that they have no relevant disclosures to present.